Spectrum of Vascular Thrombosis in Critically Ill COVID-19 Patients: From Bench to the Bedside

Ashwini Pednekar; Abhijit Raut

doi:10.5005/jp-journals-10071-24369

SEARCH WITHIN CONTENT

Online First

Spectrum of Vascular Thrombosis in Critically Ill COVID-19 Patients: From Bench to the Bedside

Ashwini Pednekar, Abhijit Raut

Keywords : COVID-associated coagulopathy, Prothrombotic milieu, Severe acute respiratory syndrome coronavirus 2, Vascular thrombosis

Citation Information : Pednekar A, Raut A. Spectrum of Vascular Thrombosis in Critically Ill COVID-19 Patients: From Bench to the Bedside. Indian J Crit Care Med 2022; 26 (12):1237-1243.

DOI: 10.5005/jp-journals-10071-24369

License: CC BY-NC 4.0

Published Online: 08-12-2022

ARTICLE
REFERENCES

Abstract

Pro-inflammatory cytokines and procoagulant factors released by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lead to thrombosis and ischemia. Pathogenesis and clinical significance of hypercoagulability and an ensuing gamut of vascular complications are explained here.

HTML PDF Share

Tiwari NR, Phatak S, Sharma VR, Agawal SK. COVID-19 and thrombotic microangiopathies. Thromb Res 2021;202:191–198. DOI: 10.1016/j.thromres.2021.04.012.
Obi AT, Barnes GD, Napolitano LM, Henke P, Wakefield TW. Venous thrombosis epidemiology, pathophysiology, and anticoagulant therapies and trials in severe acute respiratory syndrome coronavirus 2 infection. J Vas Surg Venous Lymphat Disord 2021;9:23–35. DOI: 10.1016/j.jvsv.2020.08.030.
Kreidieh F, Temraz S. Anticoagulation for COVID-19 patients: A bird's eye view. Clinical and Applied Thrombosis/Hemostasis. 2021;27:10760296211039288. DOI: 10.1177/10760296211039288.
Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, et al. Pulmonary vascular endothelitis, thrombosis, and angiogenesis in COVID-19. N Engl J Med 2020;383:120–1208. DOI: 10.1056/NEJMoa2015432.
Hariri LP, North CM, Shih AR, Israel RA, Maley JH, Villalba JA, et al. Lung histopathology in coronavirus disease 2019 as compared with severe acute respiratory sydrome and H1N1 influenza: A systematic review. Chest 2021;159(1):73–84. DOI: 10.1016/j.chest.2020.09.259.
Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E, et al. COVID- 19 and thrombotic or thromboembolic disease: Implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review. J Am Coll Cardiol 2020;75(23):2950–2973. DOI: 10.1016/j.jacc.2020.04.031.
Augustine R, Abhilash S, Nayeem A, Salam SA, Augustine P, Dan P, et al. Increased complications of COVID-19 in people with cardiovascular disease: Role of the renin–angiotensin–aldosterone system (RAAS) dysregulation. Chem Biol Interact 2022;351:109738. DOI: 10.1016/j.cbi.2021.109738.
Bourgonje AR, Abdulle AE, Timens W, Hillebrands JL, Navis GJ, Gordijn SJ, et al. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19). J Pathol 2020;251(3):228–248. DOI: 10.1002/path.5471.
Engelmann B, Massberg S. Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol 2012;13(1):34–45. DOI: 10.1038/nri3345. DOI: 10.1038/nri3345.
Vadi S, Pednekar, A, Suthar S, Sanwalka N, Ghodke K, Rabade N. Characteristics and predictive value of T-lymphocyte subset absolute counts in patients with COVID-19 associated acute respiratory failure: A retrospective study. Indian J of Crit Care Med 2022;26(11):1196–1201. DOI: 10.5005/jp-journals-10071-24352.
Sastry S, Cuomo F, Muthusamy J. COVID-19 and thrombosis: The role of hemodynamics. Thrombosis Res 2022;212:51–57. DOI: 10.1016/j.thromres.2022.02.016.
Lozier JN, Csako G, Mondoro TH, Krizek DM, Metzger ME, Costello R, et al. Toxicity of a first-generation adenoviral vector in rhesus macaques. Hum Gene Ther 2002;13(1):113–124. DOI: 10.1089/10430340152712665. DOI: 10.1089/10430340152712665.
Pavord S, Scully M, Hunt BJ, Lester W, Bagot C, Craven B, et al. Clinical features of vaccine-induced immune thrombocytopenia and thrombosis. NEJM 2021;385(18):1680–1689. DOI: 10.1056/NEJMoa2109908.

PDF Share